Hogan Lovells advised Perspective Therapeutics on a series of strategic transactions. Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX) has completed a series of strategic transactions with Lantheus Holdings (NASDAQ:...
You must be a Standard 1 Year member to access this content.
Goodwin advised Flagship Pioneering on the matter. Hogan Lovells acted for Omega Therapeutics, Inc. Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) and Cellarity Inc. announced that Novo Nordisk...
You must be a Standard 1 Year member to access this content.
Hogan Lovells has advised Gilead Sciences, Inc. on the deal. Gilead Sciences, Inc. entered into a strategic research collaboration with Dragonfly Therapeutics, a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Hogan Lovells has advised Gilead Sciences, Inc. on the deal. Gilead Sciences, Inc. entered into a strategic research collaboration with Dragonfly Therapeutics, a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised Labcorp on the deal while Jones Day represented Ascension. Labcorp, a leading global life sciences company, signed an agreement to create a comprehensive...
You must be a Standard 1 Year member to access this content.
Hogan Lovells and White & Case, LLP acted as legal counsel to Gilead. Morgan, Lewis & Bockius and Gibson Dunn advised Merck. Gilead Sciences, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
